Overview

Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis

Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the response to pioglitazone on the hepatic venous pressure gradient and peripheral vascular responsiveness to vasoconstrictors in patients with advanced (Child“s Grade B or C) cirrhosis.
Phase:
Phase 4
Details
Lead Sponsor:
Medical University of Vienna
Treatments:
Pioglitazone